In vitrobasic fibroblast growth factor (bFGF) delivery using an antithrombogenic 2‐methacryloyloxyethyl phosphorylcholine (MPC) polymer coated with a micropatterned diamond‐like carbon (DLC) film
- 23 September 2017
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 105 (12) , 3384-3391
Abstract
In this study, a newly designed drug‐release platform composed of an antithrombogenic 2‐methacryloyloxyethyl phosphorylcholine (MPC) polymer was introduced, which was impregnated with basic fibroblast growth factor (bFGF) (bFGF/MPC polymer) to enhance the endothelial cell activation. The platform was also coated with an ultrathin micropatterned diamond‐like carbon (DLC) film (DLC/bFGF/MPC polymer) to precisely control the drug release rate and the cell compatibility. The resulting DLC/bFGF/MPC polymer could effectively prolong the bFGF release rate by depositing the micropatterned DLC. The number of adherent platelets on the DLC/bFGF/MPC polymer was significantly lower (about 1/14) than that on a currently used stent made of stainless steel (SUS316L), indicating the enhanced antithrombogenicity in the DLC/bFGF/MPC polymer. The proliferation of endothelial cells on the DLC/bFGF/MPC polymer and the DLC/MPC polymer (without bFGF) were also examined. It was found that the optical density of HUVEC on the DLC/bFGF/MPC polymer determined by WST‐8 assay was higher by 25%than that on the DLC/MPC polymer (without bFGF) measured after 72 h of incubation. Our results suggest that the released bFGF that contributes to the expression of other growth factors results in the early proliferation of the HUVEC on the DLC/bFGF/MPC polymer. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 3384–3391, 2017.Keywords
Funding Information
- The Japan Society for the Promotion of Science (JSPS: “KAKENHI”): Grant-in-Aid for Scientific Research (A) (15H02298, 15KK0244)
- Grant-in-Aid for Scientific Research (C) (24560860, 15K06492)
- MEXT Grant-in-Aid for the Program for Leading Graduate Schools
This publication has 30 references indexed in Scilit:
- Local Stent-Based Release of Transforming Growth Factor–β1 Limits Arterial In-Stent RestenosisSLAS Technology, 2016
- Bare Metal Stents Versus Drug Eluting Stents: Where Do We Stand in 2015?Current Treatment Options in Cardiovascular Medicine, 2015
- Poly(2-methacryloyloxyethyl phosphorylcholine) (MPC) nanofibers coated with micro-patterned diamond-like carbon (DLC) for the controlled drug releaseJournal of Biorheology, 2015
- Basic Fibroblast Growth Factor as a Potential Stent Coating Material Inducing Endothelial Cell ProliferationJournal of Atherosclerosis and Thrombosis, 2014
- Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisThe Lancet, 2007
- Thrombosis and Drug-Eluting StentsJACC, 2007
- Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal StentsNew England Journal of Medicine, 2007
- Sirolimus and Paclitaxel on Polymer-Based Drug-Eluting StentsJACC, 2006
- Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting StentsCirculation, 2004
- Local Delivery of Vascular Endothelial Growth Factor Accelerates Reendothelialization and Attenuates Intimal Hyperplasia in Balloon-Injured Rat Carotid ArteryCirculation, 1995